HIV pre-exposure prophylaxis (PrEP) – Swedish recommendation for management 2026
Emtricitabine/tenofovir disoproxil fumarate (TDF) is approved in Sweden for use as pre-exposure prophylaxis (PrEP) in adults and adolescents at high risk of HIV infection. International guidelines ...
Authors
- Finn Filén
- Emmi Andersson (ORCID: https://orcid.org/0000-0003-3549-7400)
- Fredrik Månsson (ORCID: https://orcid.org/0000-0002-2802-0420)
- Catharina Missailidis
- Susanne Strömdahl (ORCID: https://orcid.org/0000-0002-6706-0177)
- Petra Tunbäck (ORCID: https://orcid.org/0000-0001-8423-8566)
- Jaran Eriksen (ORCID: https://orcid.org/0000-0003-1146-5615)
- Åsa Haggren
Institutions
- Karolinska University Hospital (SE)
- Uppsala University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Hindustan Aeronautics Limited (India) (IN)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Scandinavian Journal of Infectious Diseases
- Published
- 2026-08-25
- DOI
- https://doi.org/10.1080/23744235.2026.2713548
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00